Company Filing History:
Years Active: 2018
Title: **Jay Brumfield: Innovator in Pharmaceutical Compositions**
Introduction
Jay Brumfield, an accomplished inventor based in Westfield, NJ, has made significant contributions to the field of pharmaceuticals. He holds a notable patent that focuses on innovative formulations designed to combat cancer, showcasing his commitment to advancing medical science.
Latest Patents
Brumfield's patent is titled "Formulations of 3-(5-amino-2-methyl-4-oxo-4H-quinazolin-3-yl)-piperidine-2,6-dione." This patent outlines various pharmaceutical compositions and single unit dosage forms of Compound A. The invention also includes potential variations, such as enantiomers, pharmacologically acceptable salts, and a range of structural forms. Notably, this invention emphasizes methods for treating, managing, or preventing cancer, highlighting its importance in oncology.
Career Highlights
Jay Brumfield is currently associated with Celgene Corporation, a leading biopharmaceutical company renowned for its innovative therapies. His role there allows him to work at the forefront of pharmaceutical development, contributing to life-saving treatments.
Collaborations
Throughout his career, Brumfield has collaborated with colleagues like Colin Walters and William Bowen. Together, they represent a dynamic team dedicated to advancing pharmaceutical innovations.
Conclusion
In conclusion, Jay Brumfield exemplifies the spirit of innovation within the pharmaceutical industry. His patent reflects a deep understanding of both chemistry and the complexities of cancer treatment. As he continues his work with Celgene Corporation and alongside talented colleagues, Brumfield’s contributions will undoubtedly leave a lasting impact on the field of medicine.